NCT02843230View on ClinicalTrials.gov

Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

January 31, 2022

Study Completion Date

January 31, 2022

Conditions
Glioblastoma
Interventions
RADIATION

Avastin

RADIATION

Lomustine

RADIATION

Temozolomide

DEVICE

MRI

DEVICE

MRS

DEVICE

DSC

Trial Locations (1)

02114

Massachusetts general Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT02843230 - Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI | Biotech Hunter | Biotech Hunter